These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 3091132

  • 1. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L.
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [Abstract] [Full Text] [Related]

  • 2. The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.
    Rényi L.
    Br J Pharmacol; 1986 Apr; 87(4):639-48. PubMed ID: 2939912
    [Abstract] [Full Text] [Related]

  • 3. Antagonism of 5-methoxy-N,N-dimethyltryptamine-induced changes in postdecapitation convulsions in rats by repeated treatment with drugs enhancing 5-hydroxytryptamine neurotransmission.
    Archer T, Tandberg B, Rènyi L, Ross SB.
    J Pharm Pharmacol; 1985 Sep; 37(9):648-50. PubMed ID: 2867187
    [Abstract] [Full Text] [Related]

  • 4. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors.
    Gudelsky GA, Koenig JI, Jackman H, Meltzer HY.
    Psychopharmacology (Berl); 1986 Sep; 90(3):403-7. PubMed ID: 2947256
    [Abstract] [Full Text] [Related]

  • 5. 5-Hydroxytryptamine-mediated behaviour in male and female rats.
    Dickinson SL, Curzon G.
    Neuropharmacology; 1986 Jul; 25(7):771-6. PubMed ID: 3748324
    [Abstract] [Full Text] [Related]

  • 6. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ, Marsden CA, Martin KF, Palfreyman MG.
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T, Satoh S, Satoh N, Kisara K, Arai Y, Kim SK, Kinemuchi H.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [Abstract] [Full Text] [Related]

  • 8. Ejaculations induced by p-chloroamphetamine in the rat.
    Rènyi L.
    Neuropharmacology; 1985 Aug; 24(8):697-704. PubMed ID: 3837857
    [Abstract] [Full Text] [Related]

  • 9. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.
    Ask AL, Fagervall I, Huang RB, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):684-9. PubMed ID: 2770890
    [Abstract] [Full Text] [Related]

  • 10. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP, Steinberg R, Mouget-Goniot C, Worms P, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
    [Abstract] [Full Text] [Related]

  • 11. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
    Benmansour S, Brunswick DJ.
    Brain Res; 1994 Jul 11; 650(2):305-12. PubMed ID: 7953696
    [Abstract] [Full Text] [Related]

  • 12. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
    Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA.
    Psychopharmacology (Berl); 2008 Nov 11; 201(1):55-66. PubMed ID: 18604652
    [Abstract] [Full Text] [Related]

  • 13. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F.
    Br J Pharmacol; 1987 Feb 11; 90(2):335-45. PubMed ID: 3103805
    [Abstract] [Full Text] [Related]

  • 14. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G, Gabilondo AM, Miralles A, Escriba PV, García-Sevilla JA.
    Br J Pharmacol; 1993 Mar 11; 108(3):597-603. PubMed ID: 8385528
    [Abstract] [Full Text] [Related]

  • 15. The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity.
    Reimann W, Schneider F.
    Gen Pharmacol; 1993 Mar 11; 24(2):449-53. PubMed ID: 8482527
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A, Nyman L, Haapalinna A, Sirviö J.
    Pharmacol Toxicol; 2001 Jun 11; 88(6):304-12. PubMed ID: 11453370
    [Abstract] [Full Text] [Related]

  • 17. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R, Botting R, Coulson P, Spanswick G.
    Br J Pharmacol; 1984 May 11; 82(1):151-4. PubMed ID: 6428496
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors.
    Fletcher PJ, Yu PH.
    Psychopharmacology (Berl); 1989 May 11; 98(2):265-8. PubMed ID: 2502797
    [Abstract] [Full Text] [Related]

  • 19. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul 11; 18(4):793-802. PubMed ID: 7938567
    [Abstract] [Full Text] [Related]

  • 20. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP, Galva MD, Villa F, Sciaba L, Picotti GB.
    Biochem Pharmacol; 1995 Jun 29; 50(1):97-102. PubMed ID: 7605351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.